Digital Innovation Index

BOSTON – November 04, 2026 -- Sanofi ranked first in the 2026 CNS Summit Digital Innovation Index and placed in the top three in all three categories: research, clinical development and commercial. The rankings, developed with IDEA Pharma, a division of SAI MedPartners, were revealed on the CNS Summit 2026 main stage at Encore Boston Harbor.

Index ranks 30 pharma companies on public digital initiatives and investments

Now in its 11th year, the Index scores the top 30 pharmaceutical companies on digital innovation. It draws only on publicly reported initiatives and investments from July 2025 through July 2026.

The 2026 top 10 are Sanofi, Eli Lilly, AstraZeneca, Chugai, Roche, Bristol Myers Squibb, Novo Nordisk, Johnson & Johnson, Boehringer Ingelheim and Merck KGaA.

Roche, Novo Nordisk and Recursion lead individual categories

Roche led the commercial category and Novo Nordisk led clinical development. Recursion led research.